Guidelines for the detection and treatment of osteoporosis
Keywords: bisphosphonates, calcium, osteoporotic fractures, vitamin D
AbstractOsteoporotic fractures are a major cause of disability and death. If we want to effectively prevent them, we should treat individuals at highrisk of fracture. Primarily, we treat patients afterosteoporotic vertebral or hip fracture, where it is required only to exclude secondary causes of osteoporosis prior to initiating treatment. For other women after menopause and men over fifty years, the risk of fracture could be assessed using clinical factors, which are entered into the computer-driven FRAX algorithm. The measurement of bone mineral density could also be used, but we have to take into account the age and sex of subjects when interpreting the result. Treatment of osteoporosis requires a healthy lifestyle without smoking and excessive alcohol intake. The diet should be rich in calcium and protein. Regular physical exercise has positive effects on the bone as well as on the muscles and fall prevention. The addition of vitamin D is always recommended. Drugs have proven efficacy against osteoporotic fractures. We can choose between several inhibitors of bone resorption, such as estrogens, bisphosphonates, raloxifene and denosumab. Teriparatide is an anabolic drug that promotes bone formation, while strontium ranelate has a beneficial effect on both processes of bone turnover.
Download data is not yet available.
How to Cite
Kocjan T, Preželj J, Pfeifer M, Jensterle Sever M, Čokolič M, Zavratnik A. Guidelines for the detection and treatment of osteoporosis. SlovMedJour [Internet]. 1Apr.2013 [cited 19Oct.2018];82(4). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/635
Quality and safety